Cancer prevention with aspirin in hereditary colorectal cancer
- Slides: 3
Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10 year follow-up and registry-based 20 -year data in the CAPP 2 study: a double-blind, randomised, placebo-controlled trial Prof John Burn, MD, Harsh Sheth, Ph. D, Faye Elliott, MSc, Lynn Reed, Prof Finlay Macrae, MD, Jukka-Pekka Mecklin, MD, Prof Gabriela Möslein, MD, Fiona E Mc. Ronald, Ph. D, Lucio Bertario, MD, Prof D Gareth Evans, MD, Prof Anne-Marie Gerdes, MD, Judy W C Ho, MD, Prof Annika Lindblom, MD, Prof Patrick J Morrison, MD, Jem Rashbass, MD, Prof Raj Ramesar, Ph. D, Toni Seppälä, MD, Prof Huw J W Thomas, FRCP, Kirsi Pylvänäinen, Gillian M Borthwick, Ph. D, Prof John C Mathers, Ph. D, Prof D Timothy Bishop, Ph. D Alex Boussioutas, Carole Brewer, Jackie Cook, Diana Eccles, Anthony Ellis, Shirley V Hodgson, Jan Lubinski, Eamonn R Maher, Mary EM Porteous, Julian Sampson, Rodney J Scott, Lucy Side The Lancet Volume 395 Issue 10240 Pages 1855 -1863 (June 2020) DOI: 10. 1016/S 0140 -6736(20)30366 -4 Copyright © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4. 0 license Terms and Conditions
Figure 1 The Lancet 2020 3951855 -1863 DOI: (10. 1016/S 0140 -6736(20)30366 -4) Copyright © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4. 0 license Terms and Conditions
Figure 2 The Lancet 2020 3951855 -1863 DOI: (10. 1016/S 0140 -6736(20)30366 -4) Copyright © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4. 0 license Terms and Conditions
